drugset / Trial / NCT00438477

Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer

NCT00438477

Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

RATIONALE: Diagnostic procedures, such as lymphoscintigraphy using an injection under the nipple or near the tumor, may help doctors find out how far the disease has spread. PURPOSE: This clinical trial is studying two different injection methods to compare how well they find the sentinel lymph node during lymphatic mapping and sentinel lymph node biopsy in patients with invasive breast cancer.

Timeline

Start
2005-06
Primary completion
2006-08
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject isosulfan blue Diagnostic / imaging agent 3 ml Other
Subject isosulfan blue Diagnostic / imaging agent 5 ml Other

Indications